Literature DB >> 19056248

Psychosis and brain volume changes during the first five years of schizophrenia.

W Cahn1, M Rais, F P Stigter, N E M van Haren, E Caspers, H E Hulshoff Pol, Z Xu, H G Schnack, R S Kahn.   

Abstract

The underlying mechanisms explaining brain volume changes in schizophrenia are not yet understood, but psychosis might be related to these changes. Forty-eight patients with first-episode schizophrenia underwent Magnetic Resonance Imaging brain scanning at inclusion and after five years. An association was found between longer duration of psychosis, larger gray matter volume decrease and larger ventricular volume increase. These findings strongly suggest that psychosis contributes to brain volume reductions found in schizophrenia.

Entities:  

Mesh：

Year:  2008        PMID： 19056248     DOI： 10.1016/j.euroneuro.2008.10.006

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN： 0924-977X            Impact factor:   4.600


  32 in total

1.  Anosognosia in schizophrenia: hidden in plain sight.

Authors:  Douglas S Lehrer; Jennifer Lorenz
Journal:  Innov Clin Neurosci       Date:  2014-05

2.  Using longitudinal imaging to map the 'relapse signature' of schizophrenia and other psychoses.

Authors:  V L Cropley; C Pantelis
Journal:  Epidemiol Psychiatr Sci       Date:  2014-05-22       Impact factor: 6.892

3.  From stress to psychosis: whom, how, when and why?

Authors:  V Mondelli
Journal:  Epidemiol Psychiatr Sci       Date:  2014-06-06       Impact factor: 6.892

4.  Gender effects on brain changes in early-onset psychosis.

Authors:  Marta Rapado-Castro; Cali F Bartholomeusz; Josefina Castro-Fornieles; Ana González-Pinto; Soraya Otero; Inmaculada Baeza; Carmen Moreno; Montserrat Graell; Joost Janssen; Nuria Bargalló; Christos Pantelis; Manuel Desco; Celso Arango
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-01-15       Impact factor: 4.785

5.  Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis.

Authors:  Chuan Shi; Xin Yu; Eric F C Cheung; David H K Shum; Raymond C K Chan
Journal:  Psychiatry Res       Date:  2013-12-21       Impact factor: 3.222

6.  Normalization of cortical gray matter deficits in nonpsychotic siblings of patients with childhood-onset schizophrenia.

Authors:  Anand A Mattai; Brian Weisinger; Deanna Greenstein; Reva Stidd; Liv Clasen; Rachel Miller; Julia W Tossell; Judith L Rapoport; Nitin Gogtay
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-06-11       Impact factor: 8.829

7.  The effect of aerobic exercise on cortical architecture in patients with chronic schizophrenia: a randomized controlled MRI study.

Authors:  Peter Falkai; Berend Malchow; Thomas Wobrock; Oliver Gruber; Andrea Schmitt; William G Honer; Frank-Gerald Pajonk; Frank Sun; Tyrone D Cannon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-11-17       Impact factor: 5.270

Review 8.  Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches.

Authors:  Philip D Harvey; Christopher R Bowie
Journal:  Psychiatr Clin North Am       Date:  2012-07-15

Review 9.  Pharmacological cognitive enhancement in schizophrenia.

Authors:  Philip D Harvey
Journal:  Neuropsychol Rev       Date:  2009-06-09       Impact factor: 7.444

10.  Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients.

Authors:  Won Jong Chwa; Todd A Tishler; Catalina Raymond; Cathy Tran; Faizan Anwar; J Pablo Villablanca; Joseph Ventura; Kenneth L Subotnik; Keith H Nuechterlein; Benjamin M Ellingson
Journal:  Schizophr Res       Date:  2020-05-31       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.